Steven B Ketchum sold $27k of AMRN
Chief Scientific Officer at AMARIN CORP PLC\UK. 34,131 shares at an average of $0.79, traded Dec 12, 2023, filed Dec 14, 2023.
Score components
- +15RoleOfficer
- +5Trade size$27k at market
- 0Share of holdings soldSold 5.7% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-23-070510, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 12, 2023 | SOpen-market sale Ordinary Shares10b5-1 | -34,131 | $0.79 | $27k | 566,100 | Dec 14, 2023 |
Related signals
Other insiders at AMARIN CORP PLC\UK and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | AMRNbuy AMARIN CORP PLC\UK | Patrick Holt President and CEO | $16k 14,426 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.